Glazer Capital LLC Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JWSM
Jaws Mustang Acquisition Corp.
JWSM
|
+$52.5M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$29.9M |
| 3 |
AAC
Ares Acquisition Corporation
AAC
|
+$29.8M |
| 4 |
FCAX
Fortress Capital Acquisition Corp.
FCAX
|
+$21.5M |
| 5 |
SVFA
SVF Investment Corp. Class A Ordinary Shares
SVFA
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$187M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$149M |
| 3 |
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
|
+$112M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$96.2M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 69.3% |
| 2 | Technology | 10.26% |
| 3 | Industrials | 8.47% |
| 4 | Healthcare | 5.73% |
| 5 | Real Estate | 1.81% |
Similar funds
Glazer Capital LLC's Q4 2022 Portfolio in Review
As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.
By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.
Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.
- Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
- Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
- Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
- Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
- Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
- Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
- Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.
Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.